Supriya Lifescience Share Price

ABOUT Supriya Lifescience

• Industry Biotechnology & Drugs
• ISIN INE07RO01027
• BSE Code 543434
• NSE Code SUPRIYA

Supriya Lifescience Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs). The Company is primarily engaged in the manufacturing of bulk drugs and pharmaceutical chemicals. The Company exports its products in the antihistamine, anesthetics and anti-asthma therapy categories to approximately 86 countries. The Company's product portfolio consists of approximately 38 API products that offer remedies in therapeutic segments, such as antihistamines, analgesics, vitamins, anesthetics and anti-asthmatics, among others. Its products include Chlorphenamine Maleate, Pheniramine Maleate, Brompheniramine Maleate, Dexchlorpheniramine Maleate, Mepyramine / Pyrilamine Maleate, Dexbrompheniramine Maleate, Cetirizine DiHCL, Diphenhydramine HCL, Bisoprolol Fumarate, Nicorandil, Mecobalamin, Hydroxocobalamin Sulfate, Hydroxocobalamin Acetate, and Hydroxocobalamin Hydrochloride, among others. The Company has manufacturing facilities located in Maharashtra.

MANAGEMENT

• Satish Wagh Executive Chairman of the Board
• Krishna Raghunathan Chief Financial Officer
• Prachi Sathe Compliance Officer, Company Secretary
• Saloni Wagh Managing Director, Whole-Time Director
• Shivani Wagh Joint Managing Director, Whole-Time Director
• Balasaheb Sawant Whole-Time Director
• Smita Wagh Whole-Time Director